Mr Richard Anderson (Chair)
Richard has over 30 years' experience in healthcare and life science communications. Before co-founding his current business, Sciad Communications, Richard was Chair of Burson-Marsteller's healthcare practice for Europe, Middle East and Africa. This followed five years as Managing Director at Chime Communications and Bell Pottinger. Prior to that, Richard led De Facto Communications, Europe's leading life science communications agency.
Ms Lorraine Lander (Treasurer)
Lorraine is a Chartered Accountant with extensive experience in the private healthcare sector. After leaving practice, she joined BMI Healthcare and then worked at HCA Healthcare for 10 years in both hospital and central finance roles. From 2007, Lorraine was the founding CFO of CancerPartnersUK, a specialist radiotherapy provider which opened the first dedicated private centres outside London delivering the latest radiotherapy techniques. The company was backed by Apposite Capital and sold to GenesisCare in 2015. Lorraine currently holds other Non-Executive roles within the healthcare sector.
Mrs Nita Ares
Nita is an experienced specialist healthcare communications professional with a passion for enhancing awareness and understanding of life-threatening health conditions among the public, patients and healthcare professionals to make a real difference and improve lives. She has over 20 years' experience gained in both the private and public sectors, having held senior positions in the NHS and a world renowned research institution as well as a number of leading public relations consultancies. As a member of various management boards and senior management teams across both global and UK agencies Nita was responsible for delivering impactful growth and award winning public relations and education campaigns. Nita currently provides freelance communications consultancy to a number of healthcare businesses and agencies.
Mr Peter Beverley
Peter Beverley brings 15 years of consulting experience, at McKinsey & Company and Eden McCallum. In between, he built early stage technology and service businesses. He now has a strategy consultancy, specializing in business growth and change, and is an Executive Education faculty tutor at London Business School. He served as a trustee of Caldecott Foundation from 2004-2013.
Dr Kate Brown
Kate is Director of Learn English at Home, an ambitious local charity supporting vulnerable ethnic minority adults in Kingston and Richmond. She has worked in third sector leadership since 2010, before that teaching in secondary schools in the UK and abroad.
Mrs Aisling Burnand CBE
Aisling Burnand CBE is a cancer patient and a lifelong supporter of health research. Her most recent role was Chief Executive of the Association of Medical Research where she represented the interests of over 150 medical research charities and the patients they serve. In 2021, she was diagnosed with bowel cancer and stepped down from her full-time position deciding to dedicate her time and experience to advocating for better patient outcomes from research. Aisling's previous roles include Chief Executive of the BioIndustry Association and Executive Director of Policy and Public Affairs at CRUK. She's currently a trustee of LifeArc, a medical research charity and a member of HDRUK's Public Advisory Board. She was awarded an MBE in 2007 for services to science and CBE in 2022 for services to the charitable sector.
Mr Ben Butler
Ben is a communications professional with 20 years experience leading digital innovation and change projects. The constant in his career is the belief that technological innovation, built on consumer insights and data, married with impactful communications have the potential to dramatically improve health outcomes. After a decade leading the Drinkaware Trust's Digital, Communications and Marketing functions, Ben is now Executive Director for External Affairs at the Royal College of Obstetricians and Gynaecologists, passionately driving forward the College's mission to improve the health of women and girls around the globe.
Mr Stephen Fenwick
Stephen qualified in medicine from Nottingham University in 1995, subsequently training in hepatobiliary and liver transplant surgery. For his Doctorate he studied the role of COX-2 in the development of colorectal cancer liver metastases. In 2008 he was appointed Consultant Hepatobiliary Surgeon at Aintree University Hospital in Liverpool, and Honorary Clinical Senior Lecturer at the University of Liverpool. He is the Clinical Lead of the Department of Hepatobiliary Surgery, the Director of the Mersey and Cheshire Hepatobiliary Cancer Specialist Multi-disciplinary Team, and the Clinical Director of cancer services within his hospital. He is also associate Clinical Director for cancer within the North West Coast Strategic Clinical Network.
Mr Joe Higgins
A computer scientist by education and accountant by qualification, Joe Higgins has spent most of his career in finance and financial services. He held a number of senior roles with Bank of Scotland, HBOS, Lloyds Banking Group and latterly as CEO and largest shareholder and CEO of Certus. He has extensive experience of managing through turbulent times and implementing strategic changes gained in periods as Head of Mortgages for HBOS during the 2007-08 financial crisis and Chief Executive of Bank of Scotland (Ireland) through the closure of this business.
Joe led the negotiations on behalf of Certus to secure the contract to manage the run-down of BoSI's £26bn loan book. The contract was one of the largest ever awarded by Lloyds Banking Group and involved the transfer of over 800 staff. Following the successful completion of the contract, Joe has accepted a number of non-executive roles. Joe is a Certified Bank Director and a Fellow of the Institute of Chartered Accountants in Ireland.
Mr Mauro Mattiuzzo
Mauro is a retired partner with international law firm Norton Rose Fulbright. He became actively involved with bowel cancer following his wife's diagnosis some 20 years ago, since when he been an active fundraiser for the charity, most recently completing the Ride London 100 in 2015 and 2016.
Mr John Schofield
John is a Consultant Cellular Pathologist at the Kent Oncology Centre in Maidstone, and visiting Professor at the University of Kent. He has a special interest in colorectal pathology and is professional and clinical advisor to the NHS Bowel Cancer Screening Programme. A previous council member of the Association of Coloproctology of Great Britain and Ireland, and author of more than 80 peer reviewed scientific articles and 6 chapters in specialist textbooks, Professor Schofield is married with two daughters and lives in Blackheath.
Mr John Stebbing
John is a consultant surgeon at the Royal Surrey County Hospital NHS Foundation Trust in Guildford where he is Chief of Service for the Division of Surgery and Clinical Director of the Surrey Bowel Cancer Screening Centre.
He studied medicine at St John's College, Cambridge and Guy's Hospital in London and qualified with Distinction in Surgery in 1987. He was awarded a MRC Clinical Training Fellowship in 1994 to pursue a period of research which led to appointment as a Hunterian Professor (Royal College of Surgeons of England) and award of the John of Arderne Medal (Royal Society of Medicine) in 1996.
His professional focus in recent years has been in bowel cancer screening and quality in endoscopy. From 2011 to 2017, he was Chair of the Joint Advisory Group on GI Endoscopy which is the body which awards accreditation for endoscopy services across the UK and supports training for the endoscopists of the future. He is a member of the National Bowel Cancer Screening Advisory Committee (BSAC) and is Professional Clinical Advisor to the screening quality assurance service (SQAS) in the South East of England.
Dr Diana Tait
Diana is a Consultant Clinical Oncologist based at the Royal Marsden Hospital since 1988. She has a specialist interest in Upper Gastrointestinal, Colorectal, Hepatobiliary, Anal and Breast cancers. Her main research interests focus around using new radiotherapy technologies to improve treatment delivery, reduce side effects and improve patient outcomes. She has a special interest in the late consequences of treatment and survivorship issues. She is presently Chair of the National Radiotherapy Awareness Programme (RAP), a cross-sector group seeking to raise public awareness of radiotherapy and its benefits to patients. Diana has an extensive research portfolio and is currently Principle Investigator on two clinical trials, one a rectal cancer study which involves intensive follow-up for patients who may be able to avoid surgery by adopting a "Watch and Wait" policy. The other is a rectal cancer study investigating the best time to perform surgery following pre-operative chemo-radiation.
Ms Angie Wiles
Angie Wiles is a highly experienced senior business leader and healthcare communications professional, business mentor and Executive Coach who enjoys the challenge of helping clients find and communicate their point of 'difference'. Angie worked for three of the UK's leading PR consultancies before establishing industry-leading communications and PR business, Virgo Health, building it into one of the most successful UK healthcare consultancies and growing it to a global stage. She is now the proud Founder and CEO of The Difference Collective, a unique communications and content 'non-agency' for the health sector. Here, a diverse range of talented, senior-level experts work together to offer our clients expertise in healthcare sector communications, content and consultancy.